CD19 Recombinant Rabbit Monoclonal Antibody

The human CD19 antigen is a transmembrane glycoprotein belonging to the immunoglobulin (Ig) superfamily, which initiates a series of biological responses that are likely to be of central importance to B-cell signaling and/or growth regulation and the development of a humoral immune response.CD19 is specifically expressed in normal and neoplastic B cells, as well as follicular dendritic cells. In normal tissues, it is expressed from pre-B cells until the terminal differentiation to plasma cells. And in tumors, its expression is highly conserved on most B cell tumors. It is expressed in most acute lymphoblastic leukemias (ALL), chronic lymphocytic leukemias (CLL) and B cell lymphomas.CD19 is one of the most reliable surface biomarker for B cells and the CD19 monoclonal antibodies have been explored for lymphoma therapy.

Specifications

Catalog No.
BX50041
Clone No.
BP6046
Application
IHC-P
Subcellular location
Membrane
Control
Tonsil
Recommended method
HIER
Volume
100μl/vial, 1ml/vial
Dilution
1:100-1:200
Immunogen
Synthetic peptide corresponding to CD19 residues within aa456-556 of CD19 was used as an immunogen.

Reference

1.Wang K, et.al, Exp Hematol Oncol. 2012 Nov 29;1(1):36.
2.Hammer O, et.al, MAbs. 2012 Sep-Oct;4(5):571-7.

Support Documents

Order

  • E-mail : sales@biolynx.cn

Contact Us

Address
Hangzhou Bailing (Biolynx)  Biotechnology Co., Ltd. Room 1303 Bldg 5, #688 Bin’an Road Tianhe High-tech Park, Binjiang District Hangzhou, Zhejiang, China
310052
Phone & Fax
+86 571 88177680
+86 571 88177681
Web & Mail
Email:sales@biolynx.cn
www.biolynxtec.com

Follow Us

Scan QR Codes on Your Phone